N/A
Manufactured by Validus Pharmaceuticals LLC
15,362 FDA adverse event reports analyzed
Last updated: 2026-04-15
BENAZEPRIL HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Validus Pharmaceuticals LLC. The most commonly reported adverse reactions for BENAZEPRIL HYDROCHLORIDE include NAUSEA, FATIGUE, DRUG INEFFECTIVE, DIZZINESS, DYSPNOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for BENAZEPRIL HYDROCHLORIDE.
Out of 7,065 classified reports for BENAZEPRIL HYDROCHLORIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 15,362 FDA FAERS reports that mention BENAZEPRIL HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include NAUSEA, FATIGUE, DRUG INEFFECTIVE, DIZZINESS, DYSPNOEA, PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Validus Pharmaceuticals LLC in connection with BENAZEPRIL HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.